Backtest: does the fair value strategy beat the market?
A valuation method is only as good as its evidence. So the backtest is open: period, universe, rules, and the years the strategy lagged.
Fully visible, no account.
What it does
- 34 years of history, adjusted for survivorship bias
- Recomputed by rules, with no hindsight picking of winners
- The weak stretches shown too, not just the average
- Method and data basis documented
Data basis: 35,000+ valued stocks, 26 models, recomputed daily.
Free and with Pro
Free
Fully visible, no account.
Pro
Pro is not required for this. Pro helps you apply the strategy to your own stocks.
Compare every difference in detail
“This tool is great. I use it every time I want to buy a stock or study a stock. You get a valid calculation if you're buying an over- or undervalued stock. A perfect tool.”
Common questions
Does a good backtest mean it will work in future?
No. Past performance is not a reliable indicator, and value strategies can lag for years.
What does survivorship-adjusted mean?
Companies that no longer exist stay in the test. Counting only survivors makes any strategy look better than it was.
Can I check the numbers?
The method, universe and rules are documented, and results are shown with period and data date.
Related
Stock watchlist with fair value and signalPortfolio check: is your portfolio fairly valued?AI stock analysis on real valuation dataStock screener: filter 29,000 stocks by 57 metricsDividend stock screener: reliable payers at a fair priceAI portfolio analysis: one screenshot of your portfolio is enoughPEG screener: find growth at a reasonable pricePiotroski F-Score screener: filter for financially strong stocksCompare two stocksUndervalued stocks